Bicyclo[2.2.2]octane-1-acetic acid, 4-[4-(4-aMino-7,7-diMethyl-7H-pyriMido[4,5-b][1,4]oxazin-6-yl)phenyl]- ,AcOH salt
|
|
Bicyclo[2.2.2]octane-1-acetic acid, 4-[4-(4-aMino-7,7-diMethyl-7H-pyriMido[4,5-b][1,4]oxazin-6-yl)phenyl]- ,AcOH salt Eigenschaften
Sicherheit
Bicyclo[2.2.2]octane-1-acetic acid, 4-[4-(4-aMino-7,7-diMethyl-7H-pyriMido[4,5-b][1,4]oxazin-6-yl)phenyl]- ,AcOH salt Chemische Eigenschaften,Einsatz,Produktion Methoden
Bicyclo[2.2.2]octane-1-acetic acid, 4-[4-(4-aMino-7,7-diMethyl-7H-pyriMido[4,5-b][1,4]oxazin-6-yl)phenyl]- ,AcOH salt Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Bicyclo[2.2.2]octane-1-acetic acid, 4-[4-(4-aMino-7,7-diMethyl-7H-pyriMido[4,5-b][1,4]oxazin-6-yl)phenyl]- ,AcOH salt Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 2)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
Hangzhou MolCore BioPharmatech Co.,Ltd. | +86-057181025280; +8617767106207 |
sales@molcore.com | China | 49734 | 58 |
- Bicyclo[2.2.2]octane-1-acetic acid, 4-[4-(4-aMino-7,7-diMethyl-7H-pyriMido[4,5-b][1,4]oxazin-6-yl)phenyl]- ,AcOH salt
- DGAT-1 inhibitor 2 (acetate)
- 4-[4-(4-amino-7,7-dimethyl-7H-pyrimido[4,5-b][1,4]oxazin-6-yl)phenyl]Bicyclo[2.2.2]octane-1-acetic acid acetate
- VDIIULSBGHKXQS-UHFFFAOYSA-N
- 2-[4-[4-(4-amino-7,7-dimethylpyrimido[4,5-b][1,4]oxazin-6-yl)phenyl]-1-bicyclo[2.2.2]octanyl]acetic acid
- 942999-67-9